APA (7th ed.) Citation

V, S., P, A., J, B., AM, B., CP, B., A, C., . . . A, L. (2026). Adolescents' experience of living with X-linked hypophosphataemia (XLH): A mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth. Orphanet journal of rare diseases, 21(1), . https://doi.org/10.1186/s13023-026-04244-2

Chicago Style (17th ed.) Citation

V, Saraff, et al. "Adolescents' Experience of Living with X-linked Hypophosphataemia (XLH): A Mixed-methods Analysis of Those Who Continued and Discontinued Burosumab Treatment After End of Skeletal Growth." Orphanet Journal of Rare Diseases 21, no. 1 (2026). https://doi.org/10.1186/s13023-026-04244-2.

MLA (9th ed.) Citation

V, Saraff, et al. "Adolescents' Experience of Living with X-linked Hypophosphataemia (XLH): A Mixed-methods Analysis of Those Who Continued and Discontinued Burosumab Treatment After End of Skeletal Growth." Orphanet Journal of Rare Diseases, vol. 21, no. 1, 2026, https://doi.org/10.1186/s13023-026-04244-2.